home / stock / nvsef / nvsef news


NVSEF News and Press, Novartis Ag Basel Akt From 10/04/21

Stock Information

Company Name: Novartis Ag Basel Akt
Stock Symbol: NVSEF
Market: OTC
Website: novartis.com

Menu

NVSEF NVSEF Quote NVSEF Short NVSEF News NVSEF Articles NVSEF Message Board
Get NVSEF Alerts

News, Short Squeeze, Breakout and More Instantly...

NVSEF - Wide-Moat Stocks On Sale - The October 2021 Heat Map

Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may be worth your time for further analy...

NVSEF - Chinese Internet Stocks: One Step Forward, Two Steps Back

Another week, another sector came under the scrutiny of the Chinese government, helping to divert market players from the internet stocks. There are silver linings from the Macau casino regulatory scrutiny that could benefit the Chinese internet sector. Baidu announced several pos...

NVSEF - UBS hunts crowded trades: Most overweight, underweight stocks

A new report from UBS looks to dig into the most crowded trades in the market - the 10 stocks that are most overweight among global active investment funds, as well as the 10 most underweight. It's gone about that by forming an active trading portfolio aggregating positions across global acti...

NVSEF - Tweedy, Browne Fund Q2 2021 Commentary

Tweedy, Browne Company LLC provides investment advisory services. The Company offers portfolio management, financial planning, and consulting services for individuals, institutions, partnerships, pension and profit-sharing plans, charitable foundations, trusts, and offshore funds. Tweedy,...

NVSEF - Tracking Kahn Brothers Portfolio - Q2 2021 Update

Kahn Brothers’ 13F portfolio value increased from $646M to $698M this quarter. BP plc and Pfizer were increased, while decreasing Nam Tai Property and BlackBerry during the quarter. The portfolio continues to be very concentrated with the top five positions accounting for ~...

NVSEF - Tracking Ken Fisher's Fisher Asset Management Portfolio - Q2 2021 Update

Fisher’s 13F portfolio value increased from ~$142B to ~$159B in Q2 2021. The Vanguard Intermediate-Term Corporate Bond ETF stake was increased substantially this quarter. The top three positions are Apple, Microsoft, and Amazon. They add up to ~14% of the portfolio. F...

NVSEF - Novartis AG (NVS) CEO Vas Narasimhan on Q2 2021 Results - Earnings Call Transcript

Novartis AG (NVS) Q2 2021 Earnings Conference Call July 21, 2021 8:00 a.m. ET Company Participants Samir Shah - Global Head of Investor Relations Vas Narasimhan - Chief Executive Officer Marie-France - President of Novartis Pharmaceuticals Susanne Schaffert - President of Novartis Oncology Ha...

NVSEF - Novartis AG 2021 Q2 - Results - Earnings Call Presentation

The following slide deck was published by Novartis AG in conjunction with their 2021 Q2 earnings call. For further details see: Novartis AG 2021 Q2 - Results - Earnings Call Presentation

NVSEF - Week In Review: Insilico Closes $255 Million Round For AI Drug Discovery/Development

Insilico Medicine, a Hong Kong company devoted to using AI to speed up drug discovery and R&D, closed a $255 million Series C round led by Warburg Pincus. Jointech, a Hangzhou medical device company, has raised $62 million over the last 15 months to support its orthopedic surgery ...

NVSEF - Novartis (NVS) Iptacopan (LNP023) Update - Slideshow

The following slide deck was published by Novartis AG in conjunction with this event. For further details see: Novartis (NVS) Iptacopan (LNP023) Update - Slideshow

Previous 10 Next 10